LipiFlow® TearScience® System
The LipiFlow® TearScience® system uses thermal pulsation therapy to clear blockages preventing healthy tear flow to the eye’s surface. This FDA-approved device gently heats and massages the inner and outer lid to effectively treat Meibomian Gland Dysfunction (MGD), a leading cause of Dry Eye Disease (DES).
Revolutionary Treatment
LipiFlow® activators are single-use sterile devices that safely and comfortably massages the meibomian glands while protecting the delicate structures of your eye. When placed comfortably, the activator delivers a combination of heat and gentle pressure (Vectored Thermal Pulses) to the inner lids with a simultaneous therapeutic motion on the outer lid. This unique combination safely removes gland obstruction or old gland content. The entire treatment takes twelve (12) minutes and, as normal gland function recovers, maximum results are usually experienced 6 to 8 weeks after treatment.
Delivering Relief
When LipiFlow treatment is properly applied, the glands can resume normal oil production or what is known as lipids. This oil is essential for a healthy tear film and for protecting the tear layer or watery layer of your eyes. In a clinical study, 90% of patients received a meibomian gland secretion score at least three times great than before treatment. 80% of patients reported a mean improvement of 50% in symptoms one month following a single treatment including relief from the effects of Dry Eye Syndrome (DES).
Schedule your Dry Eye Evaluation today
Call (727) 581-8706 to schedule your appointment
Meet Your Dry Eye Care Specialist
Neel R. Desai, M.D. is a fellowship-trained, board-certified, ophthalmologist strictly specializing in LASIK, cataract, and corneal diseases of the eye. Dr. Desai is a top graduate of the Pennsylvania State University College of Medicine and completed his fellowship in cornea, cataract, and refractive surgery at the Wilmer Eye Institute at Johns Hopkins University. He is recognized throughout the country and internationally as one of only 100 surgeons able to perform advanced corneal transplants and another complex cataract, corneal and refractive procedures. He holds pending patents to new surgical products and advanced cornea surgical procedures of his own design. Additionally, Dr. Desai has authored many book chapters in his field of study and continues to write articles in peer review journals.
